A subscription to JoVE is required to view this content. Sign in or start your free trial.
We present a protocol of creating right ventricular dysfunction in a pig model by inducing ARDS. We demonstrate invasive monitoring of left and right ventricular cardiac output using flow probes around the aorta and the pulmonary artery, as well as blood pressure measurements in the aorta and pulmonary artery.
One of the leading causes of morbidity and mortality in patients with heart failure is right ventricular (RV) dysfunction, especially if it is due to pulmonary hypertension. For a better understanding and treatment of this disease, precise hemodynamic monitoring of left and right ventricular parameters is important. For this reason, it is essential to establish experimental pig models of cardiac hemodynamics and measurements for research purpose.
This article shows the induction of ARDS by using oleic acid (OA) and consequent right ventricular dysfunction, as well as the instrumentation of the pigs and the data acquisition process that is needed to assess hemodynamic parameters. To achieve right ventricular dysfunction, we used oleic acid (OA) to cause ARDS and accompanied this with pulmonary artery hypertension (PAH). With this model of PAH and consecutive right ventricular dysfunction, many hemodynamic parameters can be measured, and right ventricular volume load can be detected.
All vital parameters, including respiratory rate (RR), heart rate (HR) and body temperature were recorded throughout the whole experiment. Hemodynamic parameters including femoral artery pressure (FAP), aortic pressure (AP), right ventricular pressure (peak systolic, end systolic and end diastolic right ventricular pressure), central venous pressure (CVP), pulmonary artery pressure (PAP) and left arterial pressure (LAP) were measured as well as perfusion parameters including ascending aortic flow (AAF) and pulmonary artery flow (PAF). Hemodynamic measurements were performed using transcardiopulmonary thermodilution to provide cardiac output (CO). Furthermore, the PiCCO2 system (Pulse Contour Cardiac Output System 2) was used to receive parameters such as stroke volume variance (SVV), pulse pressure variance (PPV), as well as extravascular lung water (EVLW) and global end-diastolic volume (GEDV). Our monitoring procedure is suitable for detecting right ventricular dysfunction and monitoring hemodynamic findings before and after volume administration.
Right ventricular (RV) dysfunction is a major cause of morbidity and mortality in patients with heart failure1, especially if the underlying cause is pulmonary hypertension2. The RV pumps blood into the low-resistance pulmonary system, which is normally associated with high compliance. Therefore, the RV is characterized by low peak systolic pressure. It also generates one sixth the stroke work compared with the left ventricle (LV)3. Due to its thinner muscle, the RV is very vulnerable to a change in pre- and afterload4,5. The isovolumic phases of contraction and relaxation during systole and diastole in the RV are not as distinct as in the LV. The examination of left and right ventricular hemodynamic parameters is highly important in therapy of critically ill patients with acute right heart distress4,7, because RV failure increases short-term mortality significantly6.
Preload parameters like the central venous pressure (CVP) and left ventricular preload parameters like pulmonary capillary wedge pressure (PCWP) have been used for a long time to determine volume status of patients. Lately, it has been shown that these parameters alone are not suitable to detect a patient's need of fluids8,9,10. Recognizing fluid responsiveness is essential to detect and treat volume deprivation and volume overload in patients with RV dysfunction. Avoiding volume overload is essential to decrease the mortality and length of intensive care unit (ICU) stay in these patients.
With this study, we established a pig model of right ventricular dysfunction that is consistent and replicable. Due to its similarity to humans, it is necessary to establish consistent and reproducible experimental large animal models of cardiac hemodynamics and measurements for research purpose.
This prospective experimental trial with 21 anesthetized male and female domestic pigs (German landrace) at the age of 3–6 months with a body weight between 45-55 kg was approved by the Governmental Commission on the Care and Use of Animals of the City of Hamburg (Reference-No. 18/17). According to the ARRIVE guidelines, all experiments were carried out and all animals received care in compliance with the 'Guide for the Care and Use of Laboratory Animals' (NIH publication No. 86-23, revised 1996)11.
1. Flow Probe Two-point Calibration
2. Millar Catheter Calibration
3. Preparation of the Pig
4. Vital Parameter Measurements
5. Surgical Preparation of the Heart
6. Assessment and Data Acquisition
7. Volume Optimizing
8. Induction of ARDS with Right Ventricular Dysfunction
9. Volume Optimizing
10. Finalization
Our animal model shows a broad variety of hemodynamic parameters in pigs. Due to its similarity in size and hemodynamics, one can easily use the exact same equipment as used in humans to get similar results. However, anesthesia values are based on experience and may change based on weight/ age/ strain of pig. A veterinarian should be consulted to evaluate anesthetic plan.
Results of previous OA induced acute lung inju...
ARDS, complicated by pulmonary hypertension, is a very deadly disease. For patients suffering from this condition, further information about treating it is necessary. When working and researching with living creatures, it is very important to be as sensible as possible. In this case it is necessary to gather as much information as possible in one experiment.
There are some critical surgical steps in an open-beating heart model like this. To not use pigs unnecessarily, there must be an experien...
Daniel A. Reuter is a member of Pulsion Medical Advisory Board. Constantin J.C. Trepte has received honorary award for lectures by Maquet. All other authors declare no conflicts of interest.
The authors have no acknowledgements.
Name | Company | Catalog Number | Comments |
Animal Bio Amp | ADInstruments | FE136 | |
Quad BridgeAmp | ADInstruments | FE224 | |
Power Lab 16/35 | ADInstruments | 5761-E | |
LabChart 8.1.8 Windows | ADInstruments | ||
Pulmonary artery catheter 7 F | Edwards Lifesciences Corporation | 131F7 | |
Prelude Sheath Introducer 8 F | Merit Medical Systems, Inc. | SI-8F-11-035 | |
COnfidence Cardiac Output Flowprobes | Transonic | AU-IFU-PAUProbes-EN Rev. A 4/13 | |
Adrenalin | Sanofi | 6053210 | |
Oleic acid | Sigma Aldrich | 112-80-1 | |
Magnesium Verla | Verla | 7244946 | |
Ketamin | Richter Pharma AG | BE-V433246 | |
Azaperon | Sanochemia Pharmazeutika AG | QN05AD90 | |
Midazolam | Roche Pharma AG | 3085793 |
Request permission to reuse the text or figures of this JoVE article
Request PermissionExplore More Articles
This article has been published
Video Coming Soon
Copyright © 2025 MyJoVE Corporation. All rights reserved